• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症中心肺循环的左心与右心交汇:心内科医生和风湿科医生面临的临床挑战。

Pulmonary Circulation on the Crossroads Between the Left and Right Heart in Systemic Sclerosis: A Clinical Challenge for Cardiologists and Rheumatologists.

机构信息

Institute of Clinical Physiology, National Research Council, Via Moruzzi, 1, Pisa 56124, Italy.

Department of Cardiology, University Hospital of Nancy, Institut Lorrain du Cœur et des Vaisseaux, 5 Rue du Morvan, 54500 Vandœuvre-lès-Nancy, France.

出版信息

Heart Fail Clin. 2018 Jul;14(3):271-281. doi: 10.1016/j.hfc.2018.02.004.

DOI:10.1016/j.hfc.2018.02.004
PMID:29966626
Abstract

Involvement of the right heart-pulmonary circulation system in systemic sclerosis is a typical feature, with critical prognostic implications. Pulmonary hypertension may occur in association with interstitial lung disease or as a result of an isolated pulmonary vascular disease that may affect both the precapillary arterioles and the postcapillary venules, as well as a consequence of left heart involvement. These apparently different phenotypes often underlie a significant pathophysiologic overlap, which makes the diagnosis and management of these patients highly complex and uncertain.

摘要

系统性硬化症中右心-肺循环系统的受累是一个典型特征,具有重要的预后意义。肺动脉高压可能与间质性肺疾病相关,也可能是由于孤立性肺血管疾病引起,这种疾病可能影响毛细血管前小动脉和毛细血管后小静脉,也可能是由于左心受累引起。这些明显不同的表型通常存在显著的病理生理学重叠,这使得这些患者的诊断和管理变得非常复杂和不确定。

相似文献

1
Pulmonary Circulation on the Crossroads Between the Left and Right Heart in Systemic Sclerosis: A Clinical Challenge for Cardiologists and Rheumatologists.系统性硬化症中心肺循环的左心与右心交汇:心内科医生和风湿科医生面临的临床挑战。
Heart Fail Clin. 2018 Jul;14(3):271-281. doi: 10.1016/j.hfc.2018.02.004.
2
[Pulmonary hypertension in connective tissue disease].[结缔组织病中的肺动脉高压]
Z Rheumatol. 2018 Apr;77(3):219-230. doi: 10.1007/s00393-018-0443-4.
3
Evaluation and management approaches for scleroderma lung disease.硬皮病肺病的评估与管理方法
Ther Adv Respir Dis. 2017 Aug;11(8):327-340. doi: 10.1177/1753465817713680. Epub 2017 Jun 16.
4
[Pulmonary involvement in systemic scleroderma].[系统性硬化症中的肺部受累]
Bull Acad Natl Med. 2011 Jan;195(1):79-90; discussion 90-2.
5
Monitoring and Diagnostic Approaches for Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis.系统性硬化症患者肺动脉高压的监测与诊断方法
Rheum Dis Clin North Am. 2015 Aug;41(3):489-506. doi: 10.1016/j.rdc.2015.04.009. Epub 2015 May 20.
6
[Screening and diagnosis of pulmonary arterial hypertension. Comments regarding the latest guidelines from the European Societies of Cardiology and of Pulmonology].[肺动脉高压的筛查与诊断。关于欧洲心脏病学会和呼吸病学会最新指南的评论]
Presse Med. 2010 Jun;39 Suppl 1:1S16-21. doi: 10.1016/S0755-4982(10)70003-8.
7
Screening and therapy of pulmonary hypertension in systemic sclerosis.系统性硬化症中肺动脉高压的筛查与治疗
Curr Opin Rheumatol. 2007 Nov;19(6):598-603. doi: 10.1097/BOR.0b013e3282ec67d4.
8
Interactions between rheumatologists and cardio-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosis.在评估和使用与系统性硬皮病相关的肺动脉高压的结局指标时,风湿病学家和心肺病学家之间的相互作用。
Clin Exp Rheumatol. 2010 Mar-Apr;28(2 Suppl 58):S47-52. Epub 2010 Jun 10.
9
Dyspnea due to pulmonary hypertension and interstitial lung disease in scleroderma: room for improvement in diagnosis and management.硬皮病中由肺动脉高压和间质性肺疾病导致的呼吸困难:诊断和管理方面仍有改善空间。
J Rheumatol. 2006 Sep;33(9):1723-5.
10
Pulmonary arterial hypertension in systemic sclerosis: can we predict responders for successful therapy?系统性硬化症中的肺动脉高压:我们能否预测成功治疗的反应者?
J Rheumatol. 2009 Apr;36(4):665-6. doi: 10.3899/jrheum.081322.

引用本文的文献

1
Multimodal Screening for Pulmonary Arterial Hypertension in Systemic Scleroderma: Current Methods and Future Directions.系统性硬化症中肺动脉高压的多模式筛查:当前方法与未来方向
Medicina (Kaunas). 2024 Dec 27;61(1):19. doi: 10.3390/medicina61010019.
2
The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis.多学科医疗团队在系统性硬化症患者管理中的作用
J Multidiscip Healthc. 2022 Apr 20;15:815-824. doi: 10.2147/JMDH.S295478. eCollection 2022.
3
A review of exercise pulmonary hypertension in systemic sclerosis.
系统性硬化症运动性肺动脉高压综述。
J Scleroderma Relat Disord. 2019 Oct;4(3):225-237. doi: 10.1177/2397198319851653. Epub 2019 Jun 14.
4
sPAP/PAAT Ratio as a New Index of Pulmonary Vascular Load: A Study in Normal Subjects and Ssc Patients with and without PH.sPAP/PAAT比值作为肺血管负荷的新指标:对正常受试者以及合并和不合并肺动脉高压的系统性硬化症患者的研究
Pathophysiology. 2022 Mar 15;29(1):134-142. doi: 10.3390/pathophysiology29010012.
5
The perpetual sword of Damocles: Cardiac involvement in systemic sclerosis and the role of non-invasive imaging modalities in medical decision making.达摩克利斯之剑高悬:系统性硬化症中的心脏受累及非侵入性成像方式在医疗决策中的作用。
Eur J Rheumatol. 2020 Oct;7(Suppl 3):S203-S211. doi: 10.5152/eurjrheum.2020.19110. Epub 2020 Jul 20.
6
Cardiac complications in systemic sclerosis: early diagnosis and treatment.系统性硬化症的心脏并发症:早期诊断与治疗。
Chin Med J (Engl). 2019 Dec 5;132(23):2865-2871. doi: 10.1097/CM9.0000000000000535.
7
Impact of the revised haemodynamic definition on the diagnosis of pulmonary hypertension in patients with systemic sclerosis.修订后的血流动力学定义对系统性硬化症患者肺动脉高压诊断的影响。
Eur Respir J. 2019 Aug 22;54(2). doi: 10.1183/13993003.00586-2019. Print 2019 Aug.
8
Echocardiography in Pulmonary Arterial Hypertension.超声心动图在肺动脉高压中的应用。
Curr Cardiol Rep. 2019 Mar 4;21(4):22. doi: 10.1007/s11886-019-1109-9.